Exercise, surgically removing belly fat improves cognition in obese, diabetic mice

(Press-News.org) Augusta, Ga. – Cognitive decline that often accompanies obesity and diabetes can be reversed with regular exercise or surgical removal of belly fat, scientists report.

A drug already used to treat rheumatoid arthritis also helps obese/diabetic adult mice regain their ability to learn and comprehend, while transplanting belly fat to a normal mouse reduces those abilities, said Dr. Alexis M. Stranahan, neuroscientist at the Medical College of Georgia at Georgia Regents University.

Studies in humans and animals indicate that obesity and diabetes – which often go hand in hand – essentially triple the risk of mild cognitive impairment as well as Alzheimer's. Stranahan focused on the effect of fat- and diabetes-associated inflammation in the brain's hippocampus, the center of learning and memory.

"These obese diabetic mice have very high levels of inflammatory cytokines and I think it's because their bodies are reacting to the invasion of fat into tissues where it does not belong," said Stranahan, corresponding author of the study in The Journal of Neuroscience. "It's almost as if the fat were an external pathogen."

Cytokines are major components of an immune response that typically targets invaders such as viruses. "They kind of mobilize all the natural killer cells and macrophages to kill off whatever is causing the pathogenic environment," Stranahan said. After clearing debris or danger, cytokine levels should subside. However in obesity, fat appears viewed as a chronic invader that keeps levels of interleukin-1 beta and inflammation high.

Like a perfect storm, obesity also weakens the protective blood-brain barrier, easing access of high interleukin-1 beta levels to the brain.

Inside the brain, interleukin-1 beta turns normally supportive microglial cells predatory. Microglia typically scarf up trash and infectious agents in the brain but when interleukin-1 beta binds to their receptors, microglia signal neurons to malfunction. Microglia then consume neuronal synapses, the major points of communication between brain cells. "This interleukin-1 beta signal makes them predatory. They eat them up," Stranahan said.

Exercise and surgery lower levels of the troublemaker in the body, so it doesn't affect the brain while the cytokine antagonist sequesters interleukin-1 beta so it can't reach receptors on the neurons or microglia.

While exercise is likely the best strategy, Stranahan suspects that this type of pharmacological intervention could also help patients who can't exercise, such as the frail and elderly. Liposuction likely is not a viable solution since scientists removed 15 to 20 percent of the mouse's body weight, far more fat than typical liposuction in humans.

Interestingly, Stranahan's previous studies have shown that healthy mice, which may run five to 10 kilometers weekly on running wheels, dropped to a fraction of that activity level as they got fat.

"They stop voluntarily exercising once they start to become obese," she said. Pushing fat mice to resume normal activity for three months, reduced obesity and brain inflammation and helped repair synaptic dysfunction. In fact, treadmill-trained and normal mice performed indistinguishably on spatial and object recognition tests.

Next steps include similar studies in a diet-induced obesity model instead of the single-gene alteration that produced the animal model for this study. The single genetic change desensitized the mice to the satiety hormone leptin so they always wanted to eat. In fact, even the mice that exercised and had surgery, continued to overeat.

Most human obesity is caused by overeating, inactivity, and possibly a genetic predisposition involving more than one gene. Early data indicates that it takes over-fed mice longer to get fat and show signs of cognitive impairment than their genetically altered counterparts, Stranahan said. But, again, the damage appears reversible.

INFORMATION: The research was funded in part by the National institute of Diabetes, Digestive and Kidney Diseases.

Toni Baker
Communications Director
Medical College of Georgia
Georgia Regents University
706-721-4421 Office
706-825-6473 Cell
tbaker@gru.edu